Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
PHASE3
60 participants
INTERVENTIONAL
2019-05-01
2030-12-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluation of the Effect of Rosuvastatin on Cisplatin-induced Nephrotoxicity and Ototoxicity
NCT04817904
Phase I Study of CBP501 and Cisplatin in Patients With Advanced Refractory Solid Tumors
NCT00551512
The Possible Protective Role of Omeprazole Against Oxaliplatin Induced Neuropathy in Cancer Patients
NCT05680870
Comparative Study of Different Doses of Magnesium as a Protective Agent in Nephrotoxicity in Cancer Patients
NCT05586009
Preventing Nephrotoxicity and Ototoxicity From Osteosarcoma Therapy
NCT01848457
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Standard hydration alone
Cisplatin with standard hydration
Standard hydration
Standard hydration alone
Cisplatin
Cisplatin
Pantoprazole high dose
Cisplatin with standard hydration with pantoprazole 1.6 mg/kg
Pantoprazole high dose
Pantoprazole 1.6 mg\\kg
Standard hydration
Standard hydration alone
Cisplatin
Cisplatin
Pantoprazole Low dose
Cisplatin with standard hydration with pantoprazole 0.6 mg/kg
Pantoprazole low dose
Pantoprazole 0.6 mg/kg
Standard hydration
Standard hydration alone
Cisplatin
Cisplatin
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Pantoprazole low dose
Pantoprazole 0.6 mg/kg
Pantoprazole high dose
Pantoprazole 1.6 mg\\kg
Standard hydration
Standard hydration alone
Cisplatin
Cisplatin
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* DM
* Elevated liver enzymes more than 3 fold.
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Sherief Abd-Elsalam
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Sherief Abd-Elsalam
Ass. Prof. Tropical Medicine
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Eman M Ghonaim, Msc
Role: PRINCIPAL_INVESTIGATOR
Demonstrator of Clinical Pharmacy
Sahar El-Haggar, Prof
Role: PRINCIPAL_INVESTIGATOR
Tanta University
Suzy Goher, Lecturer
Role: PRINCIPAL_INVESTIGATOR
Tanta University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Sherief Abd-Elsalam
Tanta, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
eman ghoneim
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.